167 related articles for article (PubMed ID: 35563269)
1. miR-196b-5p and miR-107 Expression Differentiates Ocular Sebaceous Carcinoma from Squamous Cell Carcinoma of the Conjunctiva.
de Keizer ROB; Vriends ALM; Hötte GJ; Paridaens DA; Wiemer EAC; Verdijk RM
Int J Mol Sci; 2022 Apr; 23(9):. PubMed ID: 35563269
[TBL] [Abstract][Full Text] [Related]
2. Salivary microRNA miR-let-7a-5p and miR-3928 could be used as potential diagnostic bio-markers for head and neck squamous cell carcinoma.
Fadhil RS; Wei MQ; Nikolarakos D; Good D; Nair RG
PLoS One; 2020; 15(3):e0221779. PubMed ID: 32208417
[TBL] [Abstract][Full Text] [Related]
3. Deep sequencing-based microRNA expression signatures in head and neck squamous cell carcinoma: dual strands of pre-miR-150 as antitumor miRNAs.
Koshizuka K; Nohata N; Hanazawa T; Kikkawa N; Arai T; Okato A; Fukumoto I; Katada K; Okamoto Y; Seki N
Oncotarget; 2017 May; 8(18):30288-30304. PubMed ID: 28415821
[TBL] [Abstract][Full Text] [Related]
4. Antitumor miR-150-5p and miR-150-3p inhibit cancer cell aggressiveness by targeting SPOCK1 in head and neck squamous cell carcinoma.
Koshizuka K; Hanazawa T; Kikkawa N; Katada K; Okato A; Arai T; Idichi T; Osako Y; Okamoto Y; Seki N
Auris Nasus Larynx; 2018 Aug; 45(4):854-865. PubMed ID: 29233721
[TBL] [Abstract][Full Text] [Related]
5. Plasma extracellular vesicle microRNA-491-5p as diagnostic and prognostic marker for head and neck squamous cell carcinoma.
Panvongsa W; Siripoon T; Worakitchanon W; Arsa L; Trachu N; Jinawath N; Ngamphaiboon N; Chairoungdua A
Cancer Sci; 2021 Oct; 112(10):4257-4269. PubMed ID: 34273216
[TBL] [Abstract][Full Text] [Related]
6. Identification of Tumor Suppressive Genes Regulated by
Oshima S; Asai S; Seki N; Minemura C; Kinoshita T; Goto Y; Kikkawa N; Moriya S; Kasamatsu A; Hanazawa T; Uzawa K
Int J Mol Sci; 2021 Jun; 22(12):. PubMed ID: 34201353
[TBL] [Abstract][Full Text] [Related]
7. Upregulation of miRNA-196a and miRNA-196b correlates with Bryne's prognostic score in oral squamous cell carcinoma.
Singh K; Urs AB; Koner BC; Augustine J; Shrivastava R; Narayan B
Pathol Res Pract; 2024 Jan; 253():154954. PubMed ID: 38039741
[TBL] [Abstract][Full Text] [Related]
8. Deregulation of Selected MicroRNAs in Sinonasal Squamous Cell Carcinoma: Searching for Potential Prognostic Biomarkers.
Kovaříková J; Baranová I; Laco J; Rozkošová K; Vošmíková H; Vošmík M; Dundr P; Němejcová K; Michálek J; Palička V; Chmelařová M
Folia Biol (Praha); 2019; 65(3):142-151. PubMed ID: 31638561
[TBL] [Abstract][Full Text] [Related]
9. Circulating microRNA124-3p, microRNA9-3p and microRNA196b-5p may be potential signatures for differential diagnosis of thyroid nodules.
Yu S; Liu X; Zhang Y; Li J; Chen S; Zheng H; Reng R; Zhang C; Chen J; Chen L
Oncotarget; 2016 Dec; 7(51):84165-84177. PubMed ID: 27705935
[TBL] [Abstract][Full Text] [Related]
10. Circulating miRNAs as biomarkers for oral squamous cell carcinoma recurrence in operated patients.
Yan Y; Wang X; Venø MT; Bakholdt V; Sørensen JA; Krogdahl A; Sun Z; Gao S; Kjems J
Oncotarget; 2017 Jan; 8(5):8206-8214. PubMed ID: 28030794
[TBL] [Abstract][Full Text] [Related]
11. Clinical value of miR-198-5p in lung squamous cell carcinoma assessed using microarray and RT-qPCR.
Liang YY; Huang JC; Tang RX; Chen WJ; Chen P; Cen WL; Shi K; Gao L; Gao X; Liu AG; Peng XT; Chen G; Huang SN; Fang YY; Gu YY
World J Surg Oncol; 2018 Feb; 16(1):22. PubMed ID: 29394946
[TBL] [Abstract][Full Text] [Related]
12. Prognostic microRNA signatures derived from The Cancer Genome Atlas for head and neck squamous cell carcinomas.
Wong N; Khwaja SS; Baker CM; Gay HA; Thorstad WL; Daly MD; Lewis JS; Wang X
Cancer Med; 2016 Jul; 5(7):1619-28. PubMed ID: 27109697
[TBL] [Abstract][Full Text] [Related]
13. Oral squamous cell carcinoma: microRNA expression profiling and integrative analyses for elucidation of tumourigenesis mechanism.
Manikandan M; Deva Magendhra Rao AK; Arunkumar G; Manickavasagam M; Rajkumar KS; Rajaraman R; Munirajan AK
Mol Cancer; 2016 Apr; 15():28. PubMed ID: 27056547
[TBL] [Abstract][Full Text] [Related]
14. Salivary MicroRNAs for Early Detection of Head and Neck Squamous Cell Carcinoma: A Case-Control Study in the High Altitude Mestizo Ecuadorian Population.
Salazar-Ruales C; Arguello JV; López-Cortés A; Cabrera-Andrade A; García-Cárdenas JM; Guevara-Ramírez P; Peralta P; Leone PE; Paz-Y-Miño C
Biomed Res Int; 2018; 2018():9792730. PubMed ID: 30584540
[TBL] [Abstract][Full Text] [Related]
15. Expression of microRNAs in squamous cell carcinoma of human head and neck and the esophagus: miR-205 and miR-21 are specific markers for HNSCC and ESCC.
Kimura S; Naganuma S; Susuki D; Hirono Y; Yamaguchi A; Fujieda S; Sano K; Itoh H
Oncol Rep; 2010 Jun; 23(6):1625-33. PubMed ID: 20428818
[TBL] [Abstract][Full Text] [Related]
16. MicroRNA expression patterns in oral squamous cell carcinoma: hsa-mir-99b-3p and hsa-mir-100-5p as novel prognostic markers for oral cancer.
Jakob M; Mattes LM; Küffer S; Unger K; Hess J; Bertlich M; Haubner F; Ihler F; Canis M; Weiss BG; Kitz J
Head Neck; 2019 Oct; 41(10):3499-3515. PubMed ID: 31355988
[TBL] [Abstract][Full Text] [Related]
17. Impact of Oncogenic Targets by Tumor-Suppressive
Koma A; Asai S; Minemura C; Oshima S; Kinoshita T; Kikkawa N; Koshizuka K; Moriya S; Kasamatsu A; Hanazawa T; Uzawa K; Seki N
Int J Mol Sci; 2021 Sep; 22(18):. PubMed ID: 34576110
[TBL] [Abstract][Full Text] [Related]
18. A novel saliva-based microRNA biomarker panel to detect head and neck cancers.
Salazar C; Nagadia R; Pandit P; Cooper-White J; Banerjee N; Dimitrova N; Coman WB; Punyadeera C
Cell Oncol (Dordr); 2014 Oct; 37(5):331-8. PubMed ID: 25156495
[TBL] [Abstract][Full Text] [Related]
19. A novel serum microRNA signature to screen esophageal squamous cell carcinoma.
Huang Z; Zhang L; Zhu D; Shan X; Zhou X; Qi LW; Wu L; Zhu J; Cheng W; Zhang H; Chen Y; Zhu W; Wang T; Liu P
Cancer Med; 2017 Jan; 6(1):109-119. PubMed ID: 28035762
[TBL] [Abstract][Full Text] [Related]
20. Genome-wide study of salivary miRNAs identifies miR-423-5p as promising diagnostic and prognostic biomarker in oral squamous cell carcinoma.
Romani C; Salviato E; Paderno A; Zanotti L; Ravaggi A; Deganello A; Berretti G; Gualtieri T; Marchini S; D'Incalci M; Mattavelli D; Piazza C; Bossi P; Romualdi C; Nicolai P; Bignotti E
Theranostics; 2021; 11(6):2987-2999. PubMed ID: 33456584
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
